Financial reports
Current reports
6-K
Current report (foreign)
19 Mar 24
6-K
Opthea to Participate in the Leerink Partners Global Biopharma Conference
6 Mar 24
6-K
Current report (foreign)
4 Mar 24
6-K
Opthea Reports Half-Year Financial Results and Business Updates
28 Feb 24
6-K
Current report (foreign)
20 Feb 24
6-K
Current report (foreign)
14 Feb 24
6-K
Current report (foreign)
1 Feb 24
6-K
Current report (foreign)
11 Jan 24
6-K
Current report (foreign)
27 Dec 23
6-K
Current report (foreign)
19 Dec 23
Registration and prospectus
F-3
Shelf registration (foreign)
1 Feb 22
424B3
Prospectus supplement
22 Feb 21
S-8
Registration of securities for employees
1 Dec 20
424B4
Prospectus supplement with pricing info
19 Oct 20
F-1/A
Registration statement (foreign) (amended)
15 Oct 20
8-A12B
Registration of securities on exchange
14 Oct 20
F-1/A
Registration statement (foreign) (amended)
9 Oct 20
F-1
Registration statement (foreign)
24 Sep 20
DRS/A
Draft registration statement (amended)
2 Sep 20
DRSLTR
Correspondence regarding draft registration statement
2 Sep 20
Proxies
No filings
Other
EFFECT
Notice of effectiveness
28 Feb 22
CORRESP
Correspondence with SEC
23 Feb 22
UPLOAD
Letter from SEC
7 Feb 22
EFFECT
Notice of effectiveness
19 Oct 20
CERT
Certification of approval for exchange listing
15 Oct 20
CORRESP
Correspondence with SEC
15 Oct 20
CORRESP
Correspondence with SEC
15 Oct 20
SEC STAFF
SEC staff action: Order
15 Oct 20
CORRESP
Correspondence with SEC
9 Oct 20
UPLOAD
Letter from SEC
5 Oct 20
Ownership
SC 13G/A
BAKER BROS. ADVISORS LP
14 Feb 24
SC 13G/A
REGAL FUNDS MANAGEMENT PTY LTD
14 Feb 24
SC 13G/A
Regal Partners Ltd
15 Feb 23
SC 13G/A
BAKER BROS. ADVISORS LP
14 Feb 23
SC 13G/A
REGAL FUNDS MANAGEMENT PTY LTD
14 Feb 22
SC 13G/A
BAKER BROS. ADVISORS LP
14 Feb 22
SC 13G
BAKER BROS. ADVISORS LP
16 Feb 21
SC 13G/A
REGAL FUNDS MANAGEMENT PTY LTD
10 Feb 21
SC 13G
REGAL FUNDS MANAGEMENT PTY LTD
12 Nov 20